Login / Signup

Impact of COVID-19 pandemic on research and careers of early career researchers: a DOHaD perspective.

Amita BansalGiselle Adriana AbruzzeseErandi HewawasamKyoko HasebeHirotaka HamadaZahra HoodbhoyHanna DiounouCarlos A IbáñezRosiane A MirandaThea N GoldenKozeta MilikuCarmen R Isasi
Published in: Journal of developmental origins of health and disease (2022)
The COVID-19 pandemic has exposed several inequalities worldwide, including the populations' access to healthcare systems and economic differences that impact the access to vaccination, medical resources, and health care services. Scientific research activities were not an exception, such that scientific research was profoundly impacted globally. Research trainees and early career researchers (ECRs) are the life force of scientific discovery around the world, and their work and progress in research was dramatically affected by the COVID-19 pandemic. ECRs are a particularly vulnerable group as they are in a formative stage of their scientific careers, any disruptions during which is going to likely impact their lifelong career trajectory. To understand how COVID-19 impacted lives, career development plans, and research of Developmental Origins of Health and Disease (DOHaD) ECRs, the International DOHaD ECR committee formed a special interest group comprising of ECR representatives of International DOHaD affiliated Societies/Chapters from around the world (Australia and New Zealand, Canada, French Speaking DOHaD, Japan, Latin America, Pakistan and USA). The anecdotal evidence summarized in this brief report, provide an overview of the findings of this special interest group, specifically on the impact of the evolving COVID-19 pandemic on daily research activities and its effects on career development plans of ECRs. We also discuss how our learnings from these shared experiences can strengthen collaborative work for the current and future generation of scientists.
Keyphrases
  • healthcare
  • medical students
  • mental health
  • sars cov
  • coronavirus disease
  • primary care
  • health insurance
  • public health
  • small molecule
  • current status
  • social media
  • risk assessment
  • genetic diversity